| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b5d1de0cb099ee72980dadb3b90d66d8 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-7155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-715 |
| filingDate |
2010-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1f9dc425b7f92d14c87b2df8132344d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23f2302af5ed7607005755d6ac3d2b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ecbf82c122046a5cae2723f8bf19117
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddbe3c60b52c196841a787f664e9d109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4edfa7ba45dbe340954f0f9110f1eb12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_923f091b2263383cec1a8b8ccf923840
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1454875d5f889af289c0f366692e5bcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57034a1d7bfe8b27e8e6483fbd493991
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96b697854511f5bd019dbbbe97083b9 |
| publicationDate |
2011-02-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2011027263-A1 |
| titleOfInvention |
Soluble interleukin-20 receptor |
| abstract |
A soluble receptor to IL-20 having two polypeptide subunits, IL-20RA (formerly called ZcytoR7) and IL-20RB (formerly called DIRS1). The two subunits are preferably linked together. In one embodiment one subunit is fused to the constant region of the light chain of an immunoglobulin, and the other subunit is fused to the constant region of the heavy chain of the immunoglobulin. The light chain and the heavy chain are connected via a disulfide bond. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011077207-A1 |
| priorityDate |
1999-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |